|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,263.00 ILa | +3.52% |
|
+6.75% | +0.13% |
| 06-01 | Kamada Announces FDA Approval of Its New In-House Rabies Virus Neutralization Testing Laboratory | CI |
| 05-13 | Kamada Ltd., Q1 2026 Earnings Call, May 13, 2026 |
| Market Cap | 1.31B 0 438M 384M 354M 330M 622M 41.61B 634M 4.25B 1.65B 20.43B 1.64B 1.61B 71.09B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.31B 0 438M 384M 354M 330M 622M 41.61B 634M 4.25B 1.65B 20.43B 1.64B 1.61B 71.09B | EV / Sales 2026 * |
2.23x | EV / Sales 2027 * | 2.03x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | +3.52% | ||
| 1 week | +6.75% | ||
| Current month | +3.52% | ||
| 1 month | +2.21% | ||
| 3 months | -13.00% | ||
| 6 months | +0.13% | ||
| Current year | +0.13% |
| 1 week | 2,095 |  | 2,297 |
| 1 month | 2,083 | | 2,297 |
| Current year | 2,083 | | 2,890 |
| 1 year | 1,956 | | 2,890 |
| 3 years | 1,685 | | 3,045 |
| 5 years | 1,309 | | 3,045 |
| 10 years | 1,309 | | 4,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 53 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
| Chairman | 55 | 11/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-06 | Free | Director | 113,000 | 0.1959% | ||
| 04-06 | Free | Director | 60,000 | 0.1040% | ||
| 04-06 | Free | Responsable ventes & marketing | 150,000 | 0.2600% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.52% | +6.75% | -13.76% | +15.99% | 423M | |
| +0.19% | +0.21% | +16.79% | -13.06% | 63.44B | |
| -1.56% | +1.14% | +54.57% | +217.61% | 56.98B | |
| +0.36% | +39.60% | +39.60% | +39.60% | 41.58B | |
| -0.84% | +5.65% | -50.57% | -57.33% | 38.01B | |
| -2.93% | +5.09% | +61.25% | -26.37% | 31.9B | |
| +3.53% | +19.99% | +152.70% | -40.33% | 27.79B | |
| +0.40% | +4.93% | +65.59% | +82.83% | 22.65B | |
| -0.56% | +4.05% | +1.53% | +168.92% | 17.64B | |
| +1.34% | +0.39% | +62.46% | +122.53% | 16.49B | |
| Average | +0.50% | +4.16% | +39.02% | +51.04% | 31.69B | |
| Weighted average by Cap. | +0.06% | +3.48% | +39.86% | +50.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 585M 0 196M 172M 158M 148M 278M 18.64B 284M 1.91B 738M 9.15B 736M 720M 31.84B | 642M 0 215M 189M 174M 162M 306M 20.46B 312M 2.09B 811M 10.04B 808M 791M 34.95B |
| Net income | 72.01M 0 24.15M 21.2M 19.51M 18.18M 34.29M 2.3B 34.99M 235M 90.94M 1.13B 90.66M 88.7M 3.92B | 104M 0 34.75M 30.51M 28.08M 26.17M 49.35M 3.3B 50.36M 338M 131M 1.62B 130M 128M 5.64B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | ILA 2,263.00 | +3.52% | 48,355 |
| 30/06/26 | ILA 2,186.00 | +0.51% | 117,939 |
| 29/06/26 | ILA 2,175.00 | +2.11% | 66,130 |
| 26/06/26 | ILA 2,130.00 | 0.00% | 38,326 |
| 25/06/26 | ILA 2,130.00 | -0.19% | 30,022 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KMDA Stock
Select your edition
All financial news and data tailored to specific country editions
